Abstract:Objective To investigate the effect of posterior ischemic postconditioning (RIPostC) on serum markers in patients with ischemic stroke and potential clinical significance. Methods Totally 200 patients with ischemic stroke admitted in our hospital from January 2016 to June 2017 were enrolled. Patients received standard treatments. They were randomly divided into: experimental group who received additional RIPostC for 12 months (n = 100) and control group that no extra treatments were performed (n = 100). Serum levels of homocysteine, lipid levels (high density lipoprotein, total cholesterol), platelet aggregation rate and ischemic modified albumin were measured before and after thetreatments. Results Patients in both groups experienced increased levels of serum total cysteine, total cholesterol, platelet aggregation rate and ischemic albumin and decreased levels of high density lipoprotein prior to any treatments. No significant difference (P > 0.05) in serum markers were identified between the two groups. Standard treatment induced decrease of serum cysteine, total cholesterol, platelet aggregation rate and ischemic albumin and increase of HDL in the two groups (P < 0.05). Treatment of RIPostC witnessed more dramatic alteration of serum biomarkers compared to control group (P < 0.05). Conclusion RIPostC therapy effectively reduces the severity of ischemic stroke, promoting better prognostic outcome.